A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety

ANIL YAĞCIOĞLU A. E., Akdede B. B., Turgut T., Tumuklu M., YAZICI M. K., ALPTEKİN K., ...More

JOURNAL OF CLINICAL PSYCHIATRY, vol.66, no.1, pp.63-72, 2005 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 66 Issue: 1
  • Publication Date: 2005
  • Doi Number: 10.4088/jcp.v66n0109
  • Journal Name: JOURNAL OF CLINICAL PSYCHIATRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
  • Page Numbers: pp.63-72
  • Dokuz Eylül University Affiliated: Yes

Abstract

Background: Several open trials and case studies have reported beneficial effects following the addition of risperidone for partial responders to clozapine. The purpose of this study was to carry out a placebo-controlled, randomized. double-blind trial of the efficacy, safety, and tolerability of adjunctive treatment with risperidone in patients with schizophrenia partially responsive to clozapine.